Status:
COMPLETED
A Case Report of NMDAR Encephalopathy
Lead Sponsor:
Mayo Clinic
Conditions:
Anti-NMDA Receptor Encephalitis
Mature Teratoma
Eligibility:
FEMALE
34-34 years
Brief Summary
This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is i...
Eligibility Criteria
Inclusion
- Suspected Anti-NMDA Encephalitis
Exclusion
- Inability to consent
Key Trial Info
Start Date :
June 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 19 2024
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT06915103
Start Date
June 20 2024
End Date
December 19 2024
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224